Jakarta, May 10 -- Head of the Presidential Communications Office (PCO) Hasan Nasbi has assured of the safety of the clinical trial of the M72 tuberculosis (TB) vaccine funded by Bill Gates' foundation in Indonesia.

The trial is being supervised by the World Health Organization (WHO).

Nasbi informed that the preclinical, first phase, and second phase of the trial have been completed, and the third phase is currently on.

"Currently, the focus of the test is to see the percentage of participants' recovery, not to test the safety of the vaccine," he said on Saturday.

Nasbi confirmed there have been no reports of negative effects from the vaccine during the trial.

The clinical trial has not involved the general public, but participants w...